גאלבוס 50 מ"ג

Country: Ísrael

Tungumál: hebreska

Heimild: Ministry of Health

Virkt innihaldsefni:

VILDAGLIPTIN 50 MG

Fáanlegur frá:

NOVARTIS PHARMA SERVICES AG

ATC númer:

A10BH02

Lyfjaform:

TABLETS

Stjórnsýsluleið:

PER OS

Framleitt af:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Meðferðarhópur:

VILDAGLIPTIN

Ábendingar:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Leyfisdagur:

2013-11-01